Fennec Pharmaceuticals Inc. FRX

TSX | Biotech | Specialty biopharmaceutical development
Free
No email, no account, no signup.
Exchange
TSX
Type
Biotech
Sector
Specialty biopharmaceutical development

Price & valuation

Last close
CAD 16.51
2026-08-12
1 week
+10.1 %
3 months
+30.5 %
12 months
+32.0 %
From 52w high
-6.4 %
From 52w low
+103.8 %
We're already tracking Fennec Pharmaceuticals Inc. — here are the latest events we've registered

Recent News

  • On August 5, 2026, Fennec Pharmaceuticals announced that it will release its second-quarter 2026 financial results on August 11, 2026. In the first quarter of 2026, the company reported net product sales of $15.1 million and held $40.2 million in cash and cash equivalents. The company is actively progressing commercial expansion and broader clinical studies.

What Firelda Watch includes for Fennec Pharmaceuticals Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — AI roundup of the week's news
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Fennec Pharmaceuticals Inc. will be delivered in the same format.

Want to follow Fennec Pharmaceuticals Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow 3 companies free

Email when the signal or risk changes · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Fennec Pharmaceuticals Inc. FRX
Fennec Pharmaceuticals Inc. — this picture changes. Follow free
Follow Fennec Pharmaceuticals Inc. free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.